Activation of cellular protein kinase C appears to be involved in the mechanism by which phorbol diesters induce differentiation of human myeloid leukemia cells . Protein kinase C is thought to be physiologically activated by diacylglycerol derived from receptor-mediated phosphatidylinositol hydrolysis. sn-1,2-diacylglycerols with short saturated acyl side chains (C4-C10) were synthesized and found to be potent activators of protein kinase C partially purified from HL-60 cells. These diacylglycerols were also competitive inhibitors of [3Hlphorbol dibutyrate binding to the soluble phorbol diester receptor. The most potent diacylglycerol, sn-1,2-dioctanoylglycerol, displaced >90% of
[3H]phorbol dibutyrate from the phorbol diester receptor of intact HL-60 cells. Because of probable cellular metabolism of sn-1,2-dioctanoylglycerol, hourly doses were required to maintain persistent occupancy of the phorbol diester binding site. Treatment of HL-60 cells with either phorbol 12-myristate 13-acetate or sn-1,2-dioctanoylglycerol produced identical phosphoprotein changes. Finally, sn-1,2-dioctanoylglycerol induced differentiation of the HL-60 cells into cells with morphologic characteristics of macrophages. Substitution of the hydroxyl group at position 3 with a hydrogen, chloro, or sulfhydryl moiety inactivated sn-1,2-dioctanoylglycerol. These data strengthen the hypothesis that protein kinase C activation plays a role in macrophage differentiation.
The phorbol diester tumor promoters are plant products that enhance tumor formation in two-stage models of skin carcinogenesis (1) . Paradoxically, these same compounds will rapidly induce most myeloid leukemia cells (cell lines and fresh explants from patients) to cease proliferation and to differentiate into cells with the morphologic, antigenic, biochemical, and functional properties of macrophages (2, 3) . The phorbol diesters exert these effects via a specific receptor (4, 5) . Data from several laboratories indicate that this receptor is the Ca2+-phospholipid-dependent protein kinase, termed protein kinase C (6) (7) (8) (9) . We have recently presented data that suggest activation of protein kinase C is involved in differentiation of human promyelocytic leukemia cells (HL-60) induced by phorbol diesters (10) .
Protein kinase C is regulated in vitro by Ca2 + and diacylglycerol, and is presumably activated in vivo in response to receptor-mediated phosphatidylinositol turnover, which gives rise to diacylglycerol, and/or Ca2+ flux (11) . In vitro, the phorbol diesters activate the kinase by interaction at the diacylglycerol site (12) . In intact cells, the phorbol diesters bypass the receptor-phosphatidylinositol-mediated regulatory mechanisms and activate the kinase directly (11) . Discrete and sustained changes in cellular phosphoproteins have been shown to occur during phorbol diester-induced differentiation of HL-60 cells, although evidence that these phosphorylation events are protein kinase C dependent or are involved in the process of differentiation has not been presented (13, 14) .
These data suggest that diacylglycerols may be the "endogenous phorbol" and may have a role in the physiological regulation of myeloid differentiation. To test this hypothesis, we have synthesized a series of sn-1,2-diacylglycerols with fatty acids 4-10 carbons long. These compounds have been tested for their ability (i) to compete for binding to the soluble HL-60 phorbol diester receptor and to the receptor of intact cells; (ii) to activate partially purified protein kinase C from HL-60 cells; (iii) to induce phosphoprotein changes in intact HL-60 cells; and (iv) to induce macrophage differentiation of the HL-60 cells. The results of these studies suggest that sn-1,2-diacylglycerol is the endogenous phorbol.
MATERIALS
HL-60 cells were from American Type Culture Collection; RPMI-1640 medium was from GIBCO; Pentex bovine serum albumin was from Miles; HA filters were from Millipore; Pharmalyte pH 3.5-10.0 was from Pharmacia; molecular weight standards Mr 14,000-220,000 were from Bio-Rad; Lightning Plus screens were from DuPont; DE52 and DE81 filters were from Whatman; and histone III-S, bovine serum albumin fraction V and 1,2-diolein were from Sigma. The phosphatidylserine was from Avanti Biochemicals. Phorbol 12-myristate 13- *To whom reprint requests should be addressed.
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in heptane/ethyl ether/acetic acid. Spots were located by spraying with 33% sulfuric acid and charring at 180'C.
METHODS
Preparation of sn-1,2-Diacylglycerols. Phosphatidylcholine (100 gmol) of the appropriate acyl chain length was digested in a two-phase ether/water system using 25 units of phospholipase C (17) . After 2 hr of intermittent agitation, the ether was removed under a stream of nitrogen, and the aqueous phase was extracted with chloroform/methanol (18) . The lipids were dissolved in 2 ml of chloroform and loaded on a 3-cm minicolumn of silica gel in a Pasteur pipette equilibrated with chloroform. This column was washed with 6 ml of chloroform and the combined chloroform eluates were dried under nitrogen, dissolved in chloroform, and stored at -20'C.
Preparation of sn-1-Oleoyl-2-acetylglycerol (OAG). Dioleoylphosphatidylcholine (100 mg) was digested with 10 mg of Crotalus adamanteus venom (19) . After 30 min of agitation at room temperature, the ether was evaporated and the aqueous phase was extracted as described above. The organic phase of the extract was concentrated to -0.2 ml. This residue was dissolved in 5 ml of chloroform and loaded on a 1 x 10 cm column of silica gel in chloroform. The column was washed with 5 ml of chloroform and four 5-ml vol of chloroform/methanol (9:1) to elute the oleic acid. The lysophosphatidylcholine was then eluted with 5-ml portions of chloroform/methanol/water (1:2:0.8) until thin-layer chromatography in chloroform/methanol/water/acetic acid (25:15:4:2) indicated that elution was complete. Solvents were removed by rotary evaporation until only water remained, which was removed by Iyophilization.
The lysophosphatidylcholine was dissolved in 2 ml of chloroform to which was added 0.25 ml each of pyridine and acetic anhydride. This mixture was incubated overnight at room temperature in the dark. Thin-layer chromatography indicated that no lysophosphatidylcholine remained. Methanol (1 ml) was added to consume excess acetic anhydride. After 3 hr, the solvents were largely removed under nitrogen, and residual acetic acid and pyridine were removed by chloroform/methanol extraction at neutral pH followed by washing of the lower phase with 3 portions of neutral and 3 portions of acidic preequilibrated upper phase.
The chloroform phase was dried under nitrogen, and the 1-oleoyl-2-acetylphosphatidylcholine was converted to the diacylglycerol as described above for the symmetric diacylphosphatidylcholines. Recoveries by this procedure are -75% based on dioleoylphosphatidylcholine.
Synthesis of 1,2-Dioctanoylpropanediol (Deoxy-diC8), 1,2-Dioctanoyl-3-chloropropanediol (Chloro-diC8) and 1,2-Dioctanoyl-3-thioglycerol (Thio-diC8). To 1 ml of heptane was added 0.25 ml of pyridine, 600 ,umol of octanoic anhydride, and 150 ,umol of either S( + )-1,2-propanediol, 3-chloro-1,2-propanediol or 1-thiomethyl-1-thioglycerol. After 20 hr at room temperature in the dark, the solvents were removed under nitrogen and residual pyridine was removed by acidic chloroform/methanol extraction. The lower phase was dried and the lipids were dissolved in 2 ml of heptane, which was washed with 50 mM NaOH in 50% ethanol until the aqueous ethanol phase was basic to pH paper. The heptane phase was then applied to a 0.8 x 5 cm column of silica gel in heptane and was eluted with chloroform/heptane (2:3). Fractions of 2 ml were collected and those containing the diacyl product were pooled and dried. The diacyl analogs eluted before the monoacyl and other products. The thiomethyl group was removed from the thio analog by treatment with a 4-fold excess of dithiothreitol in methanol at 750C for 24 hr.
Dithiothreitol and thio-diC8 were separated by partitioning between heptane and water, and the heptane phase was chromatographed as described above.
Enzyme/Receptor Preparation and Assays. Protein kinase C was partially purified from the cytosol of HL-60 cells and was assayed with histone 111-S or H1 as the 32P-labeled acceptor substrate, as described (10 Fig. 1 ). The filters were dried, suspended in 10 ml of Ultrafluor, and 3H was measured in a Beckman LS6800 with 40% efficiency. HL-60 phosphoproteins were analyzed by the 2-dimensional method of O'Farrell with a pH 3.5-10 gradient in the first dimension and a 5%-15% acrylamide gradient in the second dimension (14) .
RESULTS
In Vitro Effects of Diacylglycerols. Several diacylglycerols were prepared and tested for their ability to activate partially purified protein kinase C from HL-60 cells (Fig. 1A) .
and sn-1,2-dioleoylglycerol (diC18:1) were approximately equipotent in their ability to stimulate protein kinase C. sn-1,2-dihexanoylglycerol (diC6) and OAG were one order of magnitude less potent, and sn-1,2-dibutyrylglycerol (diC4) was -3 orders of magnitude less potent than diC8, diC10, or diC18:1. The diC8 analog lacking the hydroxyl at position 3 (deoxy-diC8) was inactive as a kinase activator. PDB was 3 orders of magnitude more potent than the best diacylglycerols.
To further characterize the interaction of these diacylglycerols with protein kinase C, their ability to inhibit binding of [3H]PDB to the soluble kinase preparation was determined using incubation conditions identical to those used for the kinase assays (Fig. 1B) We characterized the mechanism of this binding inhibition using OAG as a representative diacylglycerol. In a double reciprocal plot of our binding inhibition data (Fig. 2) , lines derived in the presence of OAG intersected at the y axis, indicating that the inhibition was primarily competitive.
However, the line derived in the absence of OAG consistently intersected below the others, suggesting that =20% of the inhibition may be noncompetitive, perhaps due to an OAG-induced alteration in the phosphatidylserine vesicle structure. The Ki for inhibition of binding by OAG was 0.5 x 10-6 M; expressed relative to the concentration of phosphatidylserine, the K, was 0.2% (wt/wt), which compares well with a previously reported value of 0.38% of diC18:1 (12) . Previous data from our laboratory indicated a Kd of 8.1 x 10-9 M for PDB binding to the soluble HL-60 receptor (10) . Using the DE81 binding assay, we found that the Kd value varied depending on the concentration of phosphatidylserine. With phosphatidylserine at 200 Ag/ml, the Kd was <1 x 10-9 M, while at 20 jig/ml, the Kd was -1 (Fig. 3) . The importance of the fatty acid chains present in the diacylglycerols became protein kinase C-phorbol diester receptor assays, was completely ineffective in displacing [ chloro-diC8, and thio-diC8 did not displace [3H]PDB from intact cells at concentrations up to 300 MM.
In preparation for attempting to induce cell differentiation with diacylglycerol, we examined the concentration dependence and time course of diC8 inhibition of [3H]PDB binding to intact HL-60 cells (Fig. 4 A and B) . In Fig. 4A , diC8 is compared to OAG, which has been used by others as a cell-permeable diacylglycerol (11) (Fig. 5) . In four experiments, <5% of the control cells became adherent, whereas 60% of the cells induced with phorbol dibutyrate and 50% of the cells induced with diC8 became adherent with macrophage morphology. Mortality was -10% in both treatment groups at 24 hr, >25% at 48 hr, and >50% at 60 hr. At 48 hr, neither the diC8 nor the PDB-treated cells would ingest 1-,um latex beads.
Finally, to lend further support for a common mechanism of action of diC8 and phorbol diesters, we compared phosphoprotein changes induced in the HL-60 cells by diC8 to those induced by phorbol diester. Cellular phosphoproteins were analyzed by isoelectric focusing two-dimensional gel electrophoresis. Exposure of 32P-labeled equilibrated cells to either 50 nM phorbol 12-myristate 13-acetate (PMA) or 50 gM diC8 brought about similar phosphoprotein alterations (data not shown). With both stimuli, proteins of Mr 55,000, 80,000, and 21,000 with pl 5.0, 5.4, and 5.5, respectively, demonstrated increased phosphorylation, while a protein of Mr 21,000 and pl 6.3 showed decreased phosphorylation. These changes were sustained for at least 30 min and were identical to our previous results with PMA as a stimulus (14) .
DISCUSSION
Evidence from several laboratories suggests that the phorbol diester receptor is a cellular enzyme, protein kinase C, and that activation of this kinase may be involved in the pleiotropic cellular effects of the phorbol diesters (6-11). However, as yet, genetic defects in this enzyme have not been described, so that evidence in support of a causal role for protein kinase C in any specific cellular process must remain correlative. In a previous paper, we presented data that suggested phorbol diester activation of protein kinase C played a role in the differentiation of leukemia cells into macrophages (10) . Data presented here extend these correlative observations in several ways.
First, for a series of synthetic diacylglycerols, the rank order of potencies for inhibition of phorbol diester binding to the soluble receptor correlated with the order of potencies for kinase activation (Fig. 1) . Second, diacylglycerols were competitive inhibitors of in vitro phorbol diester binding, indicating that both classes of compound interact with the same form of the enzyme, perhaps at a common site (Fig. 2) . Third, cell-permeable diacylglycerols (diC8, diC6, and OAG) effectively competed for the phorbol diester receptor of intact HL-60 cells (Figs. 3 and 4) . DiC8 was the most effective and was able to displace >90%o of specifically bound [3H]PDB, demonstrating that most phorbol diester receptors of HL-60 cells recognize diacylglycerols and, therefore, that protein kinase C may be the only biologically relevant phorbol diester receptor in these cells. Finally, the fact that treatment with diC8 and phorbol diesters led to identical changes in HL-60 phosphoproteins and cellular differentiation lends further support to the hypothesis that activation of cellular protein kinase C is involved in the process of differentiation of leukemia cells into macrophages (Fig. 5) .
Several properties of the diacyglycerols are worthy of mention. Diacylglycerols with saturated acyl side chains were as effective as diacylglycerols with unsaturated side chains in kinase activation and in inhibition of phorbol diester binding with the in vitro assays. DiC18:1, diC8, and diC10 were equipotent. However, acyl length was important in determining interaction with the regulatory site on the kinase. DiC6 and diC4 were both less active, suggesting that diacylglycerols with side chains of >6 carbons are optimal for in vitro kinase activation. Although diC18:1 and diC1o interacted with the regulatory site in vitro, neither was an effective inhibitor of the phorbol diester receptor of intact cells, indicating that side chains of 10 carbons or greater prevented interaction of these diacylglycerols with the important cellular regulatory site. DiC8 appeared to offer optimal properties of cell permeability and kinase activation.
OAG, the only other cell-permeable diacylglycerol previously used (reviewed in ref. 11) , was a good in vitro kinase activator, but it did not have access to all cellular [3H]PDB sites; hence, it may not be ideal for assessment of diacylglycerol biological effects. Finally, the hydroxyl in position 3 is critical for activity because 1,2-dioctanoylpropanediol (deoxy-diC8) was totally inactive in vitro and in vivo. Cell permeable diacylglycerols such as OAG and diC8 should be handled with caution, because they mimic many of the biological effects of phorbol diesters, which are known tumor promoters. Whether these diacylglycerols will also be active in two-stage carcinogenesis remains to be determined.
